EVOTF - Evotec SE GAAP reports Q2 results
2023-08-30 01:53:18 ET
More on Evotec SE
- Evotec SE 2023 Q2 - Results - Earnings Call Presentation
- Evotec: R&D, Customer Growth Not Enough To Offset Headwinds
- Evotec unit wins U.S. govt. contract to develop antibody products
- Novartis' Sandoz to use Evotec's technology in pact to develop biosimilars
- Evotec SE reports FY results
- Evotec gets $6.6M from Gates Foundation to develop short-regimen TB drugs
- Earnings data for Evotec SE
For further details see:
Evotec SE GAAP reports Q2 results